Chronic relapsing thrombotic thrombocytopenic purpura in pregnancy: A case report

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 5, Issue 6, 1996, Pages 328-332

  Puza, S ^a,b   Malee, M P ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Plasma exchange; Pregnancy; Relapsing thrombotic thrombocytopenic purpura

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FEVER; HEMOLYTIC ANEMIA; HUMAN; KIDNEY DISEASE; MICROCIRCULATION; PLASMA TRANSFUSION; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; PLASMA EXCHANGE; PLASMAPHERESIS; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RECURRENCE; THROMBOCYTOPENIA;

EID: 0030454581     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059609018409     Document Type: Article

References (16)

1. Rose M, Eldor A: High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med 83:437-443, 1987.
2. Hayward CP, Sutton DM, Carter WH, Campbell ED, Scott JG, Francombe WH, Shumak KH, Baker MA: Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med 154:982-987, 1994.
3. Bell WR, Braine HG, Ness PM, Kickler TS: Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 325:398-403, 1991.
4. Lian EC, Byrnes JJ, Harkness DR: Two successful pregnancies in a woman with chronic thrombotic thrombocytopenic purpura treated by plasma infusion. Am J Hematol 16:287-291, 1984.
5. Wurzel JM: TTP lesions in placenta but not fetus (letter). N Engl J Med 301:503-504, 1979.
6. Asada Y, Sumiyoski A, Hayashi T, Suzumiya J, Kaketani K: Immunohistochemistry of vascular lesions in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38:469-479, 1985.
7. Ruggenenti P, Galbusera M, Plata Carnejo R, Bellavita P, Remuzzi G: Thrombotic thrombocytopenic purpura. Evidence that infusion rather than removal of plasma induces remission of the disease. Am J Kidney Dis 21:314-318, 1993.
8. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432-1435, 1982.
9. Forsyth KD, Simpson AC, Fitzpatrick MM, Barratt TM, Levinsky RJ: Neutrophil-medicated endothelial injury in hemolytic uremic syndrome. Lancet 2:411-414, 1989.
10. Chignard M, Ballay V, Renesto P: Leucocyte elastase-mediated release of von Willebrand factor from cultured endothelial cells. Eur Respir J 6:791-796, 1993.
11. Galbusera M, Ruggenenti P, Noris M, Burnouf-Radosevich M, Benigni A, Mannucci PM, Remuzzi G: Alpha-1 antitrypsin therapy in a case of thrombotic thrombocytopenic purpura. Lancet 345:224-225, 1995.
12. Kelton JG, Warkentin TE, Hayward CP, Murphy WG, Moore JC: Calpain activity in patients with thrombotic thrombcytopenic purpura is associated with platelet microparticles. Blood 80:2246-2251, 1992.
13. Moore JC, Murphy WG, Kelton JG: Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 74:457-464, 1990.
14. Schmaier AH, Bradford H, Silver LD, Farber A, Scott CF, Schutsky D, Colman RW: High molecular weight kininogen is an inhibitor of platelet calpain. J Clin Invest 77:1565-1573, 1986.
15. Thompson CE, Damon LE, Ries CA, Linker CA: Thrombotic microangiopathies in the 1980's: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80(8): 1890-1895, 1992.
16. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, Canadian Apheresis Study Group: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393-397, 1991.